Experts reflect on COVID-19, share lessons for future pandemics
The U.S. response to the COVID-19 pandemic was full of missteps—ones that experts say can inform preparations for future global health emergencies.
Why are we seeing new malaria cases in the U.S.?
The Centers for Disease Control and Prevention recently reported several cases of locally acquired malaria in Florida and Texas—the first such cases in the U.S. in over two decades. Manoj Duraisingh explains the significance of the cases and…
Science fueled by social justice
Sydney Stanley, PhD ’23, researches infectious diseases with an eye toward improving the health of the world’s most vulnerable populations
PEPFAR program marks 20 years, 20 million lives saved
PEPFAR was the largest public health effort by one country against a single disease, and as of late last year, has provided lifesaving treatment to more than 20 million people suffering from HIV/AIDS.
Failure of tuberculosis treatment linked to bacterial resilience
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
New tools for preventing the next pandemic
Technologies such as genomic sequencing have proved to be invaluable in responding to the COVID-19 pandemic and will be important in preventing future infectious disease outbreaks, according to the panel of experts who spoke at a Harvard T.H.…
Is new malaria vaccine ‘world-changing’? Maybe.
Harvard Chan School's Dyann Wirth offers some thoughts on a new malaria vaccine and its potential impact.
Tracking and responding to the global monkeypox outbreak
Bill Hanage discusses the current state of the monkeypox outbreak and efforts to control disease spread.
Experts offer tips on taking COVID rapid tests
Experts have been urging people to take advantage of rapid COVID tests and have offered advice on how to use them most effectively.
A better antibiotic for tuberculosis treatment
PhD candidate Harim Won is developing a new type of antibiotic to address long-standing issues of lengthy treatments and drug resistance, using a new approach to turn a normal protein system in the bacterial cell against itself.
